Time-resolved Fluorescence Immunoassay Analyzer

Time-resolved Fluorescence Immunoassay Analyzer is a rapid, quantitative instrument. It tests quantitave items like cardiac markers inflammation, hormone, diabetes, etc.
> Ultra high sensitivity
> Self-Calibration
> Android system
> LIS/HIS connectivity

Innovative

It’s ground-breaking, thorough, and essential for quantitative exams. It is an autonomous in-vitro diagnostic equipment that quantitatively evaluates the concentration of analytes in blood or other samples.

Sensitive

TRFIA is a time-resolved fluorescence immunoassay that combines extended decay lifetime markers with time-resolved fluorescence to effectively remove non-specific fluorescence interference while also considerably boosting analytical sensitivity.

lmmunochemical POCT methodology

Intensity

Emission

Performance Parameter

Methodology

Bottleneck factor for existing POCT dry fluorescence methods

Existing POCT dry fluorescence methods are difficult to achieve accurate and sensitive detection requirements for clinical samples.

Different samples of endogenous substances interfere with fluorescent signals,
affecting the test results

Some biomarkers require lower detection concentrations

POCT requires more convenient quality control methods to ensure accurate test results

Poor visible or fluorescent signal stability,
short detection window

Collecting the surface of t he test card and the optical signals present by all the particles, it is currently difficult to implement

Fluorescence Immunoassay Analyzer

Existing POCT dry fluorescence strategies are hard to accomplish precise and sensitive detection requirements for clinical samples. With the development of lmmunochemical POCT innovation, TRFIA appeared.

EosCare™ – Point of Care Testing Products

Product Range for POCT


Product class	Test items	Sample type	Sample volume	Reaction time	Clinical reference	Reportable range	Qualification
Inflammation	PCT	WB/S/P	50μL	15mins	≤0.5ng/mL	0.1~100 ng/mL	IVDD Others
	hsCRP&CRP	WB/S/P	5μL	3mins	CRP: ＜10mg/L hsCRP: ≤1.0mg/L	CRP: 0.5-200mg/L hsCRP:0.5~40000mg/mL	IVDD Others
	PCT/IL-6	WB/S/P	50μL	15mins	PCT: ≤0.5ng/mL IL-6: ≤10pg/ml	PCT: 0.1~500 ng/mL IL-6: 5~50000 pg/mL	IVDD Others
	CRP/SAA	WB/S/P	5μL	3mins	CRP: ＜10mg/L SAA: 0-10mg/L	CRP: 0.5-4000ng/L； SAA: 5-500ng/mL	IVDD Others
Cardic Markers	cTnI	WB/S/P	75μL	15mins	≤0.3ng/mL	0.1~40 ng/mL	IVDD Others
	NT-proBNP	WB/S/P	30μL	15mins	<75aged: ≤300pg/mL ≥75aged: ≤450pg/mL	100~20000 pg/mL	IVDD Others
	D-Dimer	WB/P	10μL	5mins	≤0.5mg/L	0.1~10mg/L	IVDD Others
	CK-MB	WB/S/P	75μL	15mins	＜5ng/mL	1~100ng/mL	IVDD Others
	Myo	WB/S/P	75μL	15mins	＜80ng/Ml	5~500ng/mL	IVDD Others
	cTnT	WB/S/P	75μL	15mins	≤100pg/mL	30~25000pg/mL	IVDD Others
	BNP	WB/S/P	75μL	15mins	≤100pg/mL.	5~5000 pg/mL	IVDD Others
	cTnI/Myo/CK-MB	WB/S/P	75μL	15mins	cTnI≤0.3ng/mL Myo: ≤80ng/mL CK-MB: ＜5ng/mL	cTnI：0.1~40ng/mL；Myo：5~500ng/mL；CK-MB：1-100ng/mL	IVDD Others
	D-Dimer/cTnl/NT-proBNP	WB/P	50μL	15mins	D-Dimer: ≤0.5mg/L; cTnI: ≤0.3ng/mL; NT-proBNP: <75 aged: ≤300pg/mL; ≥75 aged: ≤450pg/mL.	D-Dimer：0.1mg/L~10mg/L；cTnI：0.1ng/mL~40ng/mL；NT-proBNP：100pg/mL~ 20000pg/mL。	IVDD Others
Sex Hormones	E2	WB/S/P	75μL	15mins	Males Before puberty: 0～40.33pg/mL; Adult: 0～256.68pg/mL (2) Females Before puberty: 0～32.97pg/mL; Follicular phase: 10.08～89.92pg/mL Ovulation: 100～500pg/mL; Luteal phase: 50.14～240.05pg/mL	15～3000pg/mL	IVDD Others
	β-HCG	WB/S/P	10μL	15mins	<5mIU/mL	5 ~ 2000000 mIU/mL	IVDD Others
	AMH	WB/S/P	75μL	15mins	Normal Reference Value：2~7ng/mL POR: 0.7~2ng/mL Menopause: 7ng/mL	0.1~16 ng/mL	IVDD Others
	LH	WB/S/P	75μL	15mins	Normal Reference Value: (i) Male normal range: 1.70~8.60 mIU/mL (ii) Female: Follicular phase: 2.95~13.65 mIU/mL Ovulation: 13.65~95.75 mIU/mL Luteal phase: 1.25~11.00 mIU/mL Menopause: 8.24~55.23 mIU/m	1~100 mIU/mL	IVDD Others
	PROG	S/P	30μL	15mins	1) Males 0.2～1.5 ng/mL (2) Females Follicle phase: 0.2～1.5 ng/mL; Ovulation: 0.8～3.0 ng/mL Luteal phase: 1.7～27 ng/mL; Post-menopausal: 0.1～0.8 ng/mL First trimester: 9.0～47.0 ng/mL; Second trimester: 17.0～146.0ng/mL Third trimester: 55.0～255.0ng/mL Detection range: 4.45 ～127.2 nmol/L and 1.4～40 ng/mL	0.35～60ng/mL	IVDD Others
	PRL	WB/S/P	75μL	15mins	Male 3.45～17.42 Female (not pregnant) 4.60～25.07	1～200ng/mL	IVDD Others
	FSH	WB/S/P	75μL	15mins	（1）Male: 1.50～12.40 mIU/mL （2）Female: Follicular phase: 4.46～12.43 mIU/mL Ovulation: 4.88～20.96 mIU/mL Luteal phase: 1.96～7.70 mIU/mL Menopause: 22.70～98mIU/mL	1～100 mIU/mL	IVDD Others
	TES	S/P	75μL	15mins	Adult male: 4.03-7.32ng/mL； Adult female: 0.37-0.81ng/mL； Male children: <2.54ng/mL； Female children: <0.20ng	0.2～15 ng/mL	IVDD Others
Thyroid Hormone	T3	WB/S/P	75μL	15mins	1.23~3.07nmol/L(0.8~2.0ng/mL)	0.61~92.2 nmol/L	IVDD Others
	T4	WB/S/P	75μL S/P or 150μL	15mins	66~181nmol/L(5.1~14μg/dL)	12.87~310 nmol/L	IVDD Others
	FT3	WB/S/P	75μL	15mins	2.8-7.1 pmol/L(1.82-4.61 pg/mL)	0.60-45.00 pmol/L	IVDD Others
	FT4	WB/S/P	75μL S/P or 150μL	15mins	12~22 pmol/L(0.94~1.72 ng/dL)	1-100 pmol/L	IVDD Others
	TSH	WB/S/P	75μL	15mins	0.3~4.2 mIU/L	0.1~100mIU/L	IVDD Others
	2019-nCoV Antigen	Anterior nasal/ Nasopharyngeal/ Oropharyngeal swab	100μL	10mins	Positive/Negative	/	IVDD Others
	InFluA/InFluB Ag	Anterior nasal/ Nasopharyngeal/ Oropharyngeal swab	100μL	10mins	Positive/Negative	/	IVDD Others
	2019-nCoV Neutralizing Antibody	Anterior nasal/ Nasopharyngeal/ Oropharyngeal swab	100μL	10mins	Positive/Negative	/	IVDD Others
	2019-nCoV/InFluA/InFluB Antigen	Anterior nasal/ Nasopharyngeal/ Oropharyngeal swab	100μL	10mins	Positive/Negative	/	IVDD Others
Diabetes	HbA1c	WB	5μL	5mins	4.0% - 6.0%	3%~14%	IVDD Others
Others	25-OH-VD	WB/S/P	75μL	15mins	30~100ng/mL	5.0 ~100ng/mL	IVDD Others

EosCare Point of care testing (POCT)

EosCare™ – Point of Care Testing

Time-resolved Fluorescence Immunoassay Analyzer

Time-resolved Fluorescence Immunoassay Analyzer

Innovative

Sensitive

lmmunochemical POCT methodology

Intensity

Emission

Performance Parameter

Methodology

Bottleneck factor for existing POCT dry fluorescence methods

Existing POCT dry fluorescence methods are difficult to achieve accurate and sensitive detection requirements for clinical samples.

Fluorescence Immunoassay Analyzer

EosCare™ – Point of Care Testing Products

Diagnostic Kit for Free T4

Diagnostic Kit for Free T3

Diagnostic Kit for T4

Diagnostic Kit for T3

Product Range for POCT

Diagnostic Kit for Procalcitonin (PCT)

Diagnostic Kit for D-Dimer(DD)

Diagnostic Kit for C-reactive Protein (hsCRP&CRP)

Diagnostic Kit for Cardiac Troponin l(cTnl)

Diagnostic Kit for HbA1c

EosCare™ Portable Incubator EASY-1T

Superbio 2019-nCoV/ InFluA/ InFluB Antigen Rapid Detection Kit (Lateral Flow Assay)

S·TRUST™ SPECIAL DRUG TEST

Oral Fluid Multi-Drug Test Cup SE(Colloidal Gold)

Oral Fluid Multi-Drug Test Cup PLUS(Colloidal Gold)

EosCare™ – Point of Care Testing

Time-resolved Fluorescence Immunoassay Analyzer

Time-resolved Fluorescence Immunoassay Analyzer

Innovative

Sensitive

lmmunochemical POCT methodology

Intensity

Emission

Performance Parameter

Methodology

Bottleneck factor for existing POCT dry fluorescence methods

Existing POCT dry fluorescence methods are difficult to achieve accurate and sensitive detection requirements for clinical samples.

Fluorescence Immunoassay Analyzer

EosCare™ – Point of Care Testing Products

Product Range for POCT

Shenzhen Superbio Technology - Cookies